(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate Olmesartan medoxomil 144689-63-4 Benicar Olmetec CS-866 Cs 866 6M97XTV3HD NSC-758924 DTXSID9045924 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester DTXCID7025924 TRIBENZOR COMPONENT OLMESARTAN MEDOXOMIL CS866 Medoxomil, Olmesartan RefChem:55771 1H-imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate-T287346 604-433-1 C29H30N6O6 MFCD00944911 Olmesartan medoxomil (Standard) NCGC00095136-01 Benevas Olmesartan-d4Medoxomil (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester Olsertain Olvance (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate Benicar (TN) Olmetec (TN) SR-05000001987 UNII-6M97XTV3HD votume Openvas CS-866DM CS-866RN Benicar; Olmesartanmedoxomil olmesartan-medoxomil Olmesartan medoxomilo Olmesartan medoxomil [USAN:INN:BAN] KS-1182 Spectrum_001944 Olmesartan medoxomil CRS Spectrum2_000506 Spectrum3_001676 Spectrum4_000740 Spectrum5_001556 SCHEMBL16403 SCHEMBL96150 BSPBio_003491 GTPL591 KBioGR_001040 KBioSS_002498 1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-, (5-methyl-2-oxo-1,3-dioxol-4-yl) methyl ester MLS006010109 Olmetec; Benicar; CS 866 SPECTRUM1505205 SPBio_000431 Olmesartan medoxomil (Benicar) CHEMBL1200692 CHEBI:31932 KBio2_002490 KBio2_005058 KBio2_007626 KBio3_002711 HMS1922L15 HMS2089K18 HMS2093K16 HMS3651E13 HMS3715N09 HMS3743O09 HMS5079G18 Olmesartan medoxomil (JP17/USP) OLMESARTAN MEDOXOMIL [INN] OLMESARTAN MEDOXOMIL [JAN] Pharmakon1600-01505205 OLMESARTAN MEDOXOMIL [USAN] OLMESARTAN MEDOXOMIL [VANDF] Tox21_111445 BDBM50442892 CCG-39596 EBC-12821 HY-17005R MSK158406 NSC758924 OLMESARTAN MEDOXOMIL [MART.] s1604 OLMESARTAN MEDOXOMIL [USP-RS] OLMESARTAN MEDOXOMIL [WHO-DD] AKOS015894907 AKOS015914772 AC-1601 CCG-221184 CS-0577 IH57934 NSC 758924 Olmesartan medoxomil, >=98% (HPLC) SB19327 NCGC00095136-02 NCGC00095136-03 NCGC00095136-09 (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(1-hydroxy-1-methyl-ethyl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate AZOR COMPONENT OLMESARTAN MEDOXOMIL HY-17005 OLMESARTAN MEDOXOMIL [ORANGE BOOK] SMR002203616 OLMESARTAN MEDOXOMIL [EP MONOGRAPH] SBI-0206741.P001 OLMESARTAN MEDOXOMIL [USP MONOGRAPH] CAS-144689-63-4 CS-0694888 NS00008255 O0510 SW199650-2 D01204 EN300-122375 Olmesartan medoxomil for system suitability CRS AB01275443-01 AB01275443_02 AB01275443_03 BENICAR HCT COMPONENT OLMESARTAN MEDOXOMIL L001061 SR-05000001987-1 SR-05000001987-2 BRD-K78485176-001-02-9 BRD-K78485176-001-03-7 BRD-K78485176-001-06-0 BRD-K78485176-001-07-8 Q27888058 Z1541759904 Olmesartan Medoxomil Working Standard (Secondary Reference Standard) Olmesartan medoxomil, European Pharmacopoeia (EP) Reference Standard Olmesartan medoxomil, United States Pharmacopeia (USP) Reference Standard Olmesartan medoxomil for system suitability, European Pharmacopoeia (EP) Reference Standard Olmesartan Medoxomil, Pharmaceutical Secondary Standard; Certified Reference Material (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-[[2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-4-(2-hydroxypr (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxy-2-propanyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl]-1H-imidazole-5-carboxylate (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate (5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole-5-carboxylate (5-Methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate (5-Methyl-2-oxo-1,3-dioxolen-4yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylate (5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate 1H-IMIDAZOLE-5-CARBOXYLIC ACID, 4-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-1-((2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-, (5-METHYL-2-OXO-1,3- DIOXOL-4-YL)METHYL ESTER 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imi 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 5-(1-HYDROXY-1-METHYLETHYL)-2-PROPYL-3-[2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-3H-IMIDAZOLE-4-CARBOXYLIC ACID 5-METHYL-2-OXO-[1,3]DIOXOL-4-YLMETHYL ESTER
Mostrar todos os 152 sinônimos 
